Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
Navigating the Intersection of Healthcare and Environmental Sustainability: ISPOR Europe round-up on the inclusion of environmental impact in HTA
17 January 2024
In this insight, commissioned and funded by Chiesi S.p.A, we reflect on the discussions that took place at ISPOR Europe 2023 and how environmental impact is factored into HTA.
Capturing the Broader Value of Antibiotics
23 November 2023
The value of antibiotics often extends beyond what HTA captures. The STEDI framework aims to capture that broader value and our report outlines a roadmap to realising its full potential.
Innovation for Health System Efficiency and Improvement
20 November 2023
In this report, commissioned and funded by Gilead, we explore the role of innovation in developing healthcare system efficiency amid post-pandemic challenges.
Around The World in HTAs: Greece – Late but with an Optimistic Future
18 October 2023
In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Athanassios Vozikis and Dimitrios Kourouklis take us to Greece.
NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
18 September 2023
In this report, we explore the potential impact of the National Institute of Health and Care Excellence (NICE) decision outcomes on healthcare decision-making in 12 countries across the globe (Australia, Brazil, Canada, France, Italy, Israel, Japan, South Korea, Poland, Saudi Arabia, Sweden, and the United Arab Emirates). We used quantitative and qualitative methods to estimate the level of impact and potential underlying mechanisms.
Around The World in HTAs: The Slovak Republic – Valuing the Future
13 September 2023
In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Patricia Cubi-Molla & Jake Hitch, OHE, and Róbert Babeľa, Slovak Medical University, take us to the Slovak Republic.
Are Recommendations for HTA of Gene Therapies Being Achieved?
11 September 2023
In this report, commissioned and funded by Pfizer, we explore the extent to which previous OHE recommendations for the health technology assessment (HTA) of gene therapies are being achieved in nine European countries, Australia, and Canada.
Around The World in HTAs: Egypt – The Road Ahead
31 July 2023
In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Dalia Dawoud, Pillar Pinilla-Dominguez, Caroline Bregman, and Hania El Banhawi take us to Egypt.
Around The World in HTAs: India – Let All Be Healthy
29 June 2023
In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Shalu Jain and Gayathri Kumar take us to India.